Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 14/20 | 0.47 |
| ▸ | PDCD1 | Q15116 | 6/20 | 0.47 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | PDCD1LG2 | Q9BQ51 | 4/20 | 0.44 |
| ▸ | VSIR | Q9H7M9 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2491886 | 0.91 | SCN8A (0.50) | CD274PDCD1SCN8AALDH1A1CHRM2 | |
| SCHEMBL2492086 | 0.83 | CHRM2 (0.41) | CD274SCN8AALDH1A1CHRM2PDCD1LG2 | |
| SCHEMBL5221050 | 0.80 | CHRM2 (0.67) | CD274PDCD1SCN8AALDH1A1CHRM2 | |
| SCHEMBL2491973 | 0.79 | MPO (0.44) | CD274PDCD1ALDH1A1VSIR | |
| SCHEMBL2488729 | 0.78 | KDM4E (0.55) | CD274PDCD1ALDH1A1CHRM2 | |
| SCHEMBL20962611 | 0.74 | ALDH1A1 (0.59) | ALDH1A1CHRM2 | |
| SCHEMBL2491945 | 0.73 | FFAR1 (0.36) | CD274PDCD1SCN8AALDH1A1 | |
| SCHEMBL11624233 | 0.72 | HEXA (0.36) | CD274PDCD1 | |
| SCHEMBL2494414 | 0.71 | MPO (0.47) | CD274PDCD1SCN8AALDH1A1 | |
| SCHEMBL2491496 | 0.71 | SCN8A (0.36) | CD274PDCD1SCN8AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3009123-A1 | MELANIN PRODUCTION INHIBITOR | Pola Chemical Industries Inc. (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20150328107-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-2845587-A2 | Melanin production inhibitor | Pola Chemical Industries Inc. (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-20140363389-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-8846012-B2 | Melanin production inhibitor | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-09-30 | — | — | US | disclosed |
| EP-2380567-A1 | MELANIN PRODUCTION INHIBITOR | Pola Chemical Industries Inc. (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | TYR, F12, TH | CD274 3091/4885PDCD1 3586/4885SCN8A 2532/4885 |
| US-20150328107-A1 | MELANIN PRODUCTION INHIBITOR | TYR, MC1R, F12 | CD274 2885/4885PDCD1 3433/4885SCN8A 2710/4885 |
| US-20140363389-A1 | MELANIN PRODUCTION INHIBITOR | TYR, F12, MC1R | CD274 2825/4885PDCD1 3271/4885SCN8A 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.